- Cellebrite Advances Plans to Transform and Elevate its Strategic Relationship with the U.S. Federal Government
- Cellebrite to Report Second-Quarter 2024 Financial Results on August 15, 2024
- Cellebrite Announces Availability of Industry-Leading Endpoint Inspector SaaS Solution on Amazon Web Services Marketplace
- Cellebrite Announces First-Quarter 2024 Results
- Cellebrite Announces Participation in Upcoming Investor Conferences
- Cellebrite to Report First-Quarter 2024 Financial Results on May 23, 2024
- Cellebrite revolutioniert die Datenerfassung mit bahnbrechender SaaS-Lösung als integralem Bestandteil der Case-to-Closure-Plattform des Unternehmens
- Cellebrite révolutionne la collecte de données avec une solution SaaS révolutionnaire faisant partie intégrante de la plateforme Case-to-Closure de l’entreprise
- Cellebrite Hires Marketing Veteran David Gee as Chief Marketing Officer, Ushering in Next Phase of Growth, Scale and Market Leadership
- Cellebrite Files its 2023 Annual Report on Form 20-F
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 12.84 |
---|---|
High | 13.23 |
Low | 12.74 |
Bid | 12.98 |
Offer | 13.44 |
Previous close | 12.55 |
Average volume | 1.85m |
---|---|
Shares outstanding | 205.30m |
Free float | 90.66m |
P/E (TTM) | -- |
Market cap | 2.63bn USD |
EPS (TTM) | -0.5781 USD |
Data delayed at least 15 minutes, as of Jul 22 2024 21:00 BST.
More ▼